Correlation Between Genenta Science and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Genenta Science and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genenta Science and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genenta Science SpA and Molecular Partners AG, you can compare the effects of market volatilities on Genenta Science and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genenta Science with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genenta Science and Molecular Partners.
Diversification Opportunities for Genenta Science and Molecular Partners
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Genenta and Molecular is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Genenta Science SpA and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Genenta Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genenta Science SpA are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Genenta Science i.e., Genenta Science and Molecular Partners go up and down completely randomly.
Pair Corralation between Genenta Science and Molecular Partners
Given the investment horizon of 90 days Genenta Science is expected to generate 1.85 times less return on investment than Molecular Partners. But when comparing it to its historical volatility, Genenta Science SpA is 1.09 times less risky than Molecular Partners. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 418.00 in Molecular Partners AG on August 25, 2024 and sell it today you would earn a total of 111.00 from holding Molecular Partners AG or generate 26.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 98.25% |
| Values | Daily Returns |
Genenta Science SpA vs. Molecular Partners AG
Performance |
| Timeline |
| Genenta Science SpA |
| Molecular Partners |
Genenta Science and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genenta Science and Molecular Partners
The main advantage of trading using opposite Genenta Science and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genenta Science position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Genenta Science vs. Molecular Partners AG | Genenta Science vs. MediciNova | Genenta Science vs. Anebulo Pharmaceuticals | Genenta Science vs. Champions Oncology |
| Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. HCW Biologics | Molecular Partners vs. Scpharmaceuticals | Molecular Partners vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |